Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, modest growth trend.
Left:
||||
Free cash flow yield
Latest
8.59%
↑ 16% above average
Average (9y)
7.42%
Historical baseline
Range
High:11.29%
Low:4.70%
CAGR
+6.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 8.59% | +22.7% |
| 2023 | 7.00% | +15.2% |
| 2022 | 6.08% | -24.7% |
| 2021 | 8.08% | -20.8% |
| 2020 | 10.19% | -9.7% |
| 2019 | 11.29% | +52.2% |
| 2018 | 7.42% | +33.3% |
| 2017 | 5.57% | +6.7% |
| 2016 | 5.22% | +11.0% |
| 2015 | 4.70% | - |